They write
Election day is just a month away, and this year millions of voters will decide the fates of at least seven pro-cannabis and psychedelic ballot measures in states across the nation.
Here’s a quick look at the measures up for consideration and what the various initiatives would do.
Arkansas
Issue 3, as it’s formally known in Arkansas, is one of the few proposed ballot measures still up in the air due to a legal battle between supporters and the secretary of state over how many signatures were submitted to get the question before voters.
The most recent development was just last week, when the state Supreme Court ordered the secretary of state to finish counting roughly 18,000 additional signatures that were disqualified by what the campaign called an “arbitrary” technicality. It’s not yet clear who will win out in that battle.
If ultimately successful, Issue 3 would expand the state’s existing medical marijuana program, making it easier for more patients to obtain recommendations and purchase legal cannabis. It would also legalize home cultivation.
Florida
Amendment 3, which has been primarily bankrolled by multistate operator Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), would legalize recreational marijuana in Florida. The amendment has one of the highest bars to clear, needing at least 60% of voter support to win, because it’s an amendment to the state constitution.
The ballot question has divided the Republican Party. Gov. Ron DeSantis has been a vocal opponent, but former President Donald Trump has thrown his support behind the measure.
If approved, the amendment would legalize the purchase and possession of cannabis for anyone 21 and over, but home cultivation would remain prohibited. The amendment would also allow lawmakers to authorize more cannabis business permits, but the existing 26 licensed medical marijuana companies would get first crack at recreational sales.
Massachusetts
Question 4 in Massachusetts could make the state the third in the nation to legalize some psychedelic drugs, following Oregon and Colorado.
If approved, the initiative would legalize personal possession and consumption of psilocybin, psilocin, mescaline, ibogaine and dimethyltryptamine (DMT). Large-scale commercial production and sales would remain prohibited, however, and the only sales would be permitted strictly at licensed health care facilities, which would also oversee patient use of the drugs.
Home cultivation of some psychedelics, such as magic mushrooms, would also be allowed starting in December. The larger health care rollout would be phased in over multiple years and wouldn’t be complete until 2028 at the earliest.
Go here to read full list and analysis
